Peter Crisologo, DPM
Podiatrist · Dallas, TXNPI 1710306881
Payments from drug & device makers
What this record shows
This record is dominated by other: $3,620 of the $5,962 with a category attached, or 60.7%. Integra Lifesciences Corporation accounts for 60.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $3,892 and has fallen 99.5% since, to $18 in 2025.
Across 26 payments — averaging $229.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$4K
- Legacy Ortho LLC$1K
- Stryker$699
- Bone Support Inc.$142
- Organogenesis Inc.$118
- Sanara Medtech Inc.$106
- plus $77 from 2 others
Across 13 payments — averaging $2903.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotissue Holdings Inc.$38K
What the payments were for
- Speaking & faculty fees$1182%
- Food & beverage$1,02417%
- Education$1,20020%
- Other$3,62061%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 1 | $3,620 |
| Legacy Ortho LLC | 1 | $1,200 |
| Stryker | 19 | $699 |
| Bone Support Inc. | 1 | $142 |
| Organogenesis Inc. | 1 | $118 |
| Sanara Medtech Inc. | 1 | $106 |
| Paragon 28, Inc. | 1 | $59 |
| Solventum Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$3,620
- VARIAX$293
- ASNIS$168
- CERAMENTBONE VOID FILLER$142
- CERAMENT G$142
- Apligraf$118
- Dermagraft$118
- Puraply/Affinity/NuTech$118
- CellerateRx$106
How this compares
$5,962 in reported general payments places this provider in the 75th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other podiatrist in Dallas
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
- Patrick BriggsWebster$133K
- Richard AdamsGranbury$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.